Compagnie Lombard Odier S Cm A Royalty Pharma PLC Transaction History
Compagnie Lombard Odier S Cm A
- $6.42 Billion
- Q4 2024
A detailed history of Compagnie Lombard Odier S Cm A transactions in Royalty Pharma PLC stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 8,700 shares of RPRX stock, worth $290,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,700
Previous 14,000
37.86%
Holding current value
$290,319
Previous $396,000
44.19%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$768 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$566 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...